Linde stock holds near record level as Q2 2026 earnings hit new highs
Published on 08/27/2026 at 07:07 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Linde (ISIN IE00BZ12WP82) stock is trading close to its recent record level in late August 2026, with the shares changing hands around $493.58 on August 26, 2026 during Nasdaq regular trading hours per market data. According to recent reporting on the latest quarter, the stock has remained near its high after the company delivered record sales and earnings in the second quarter of 2026.
Q2 2026 earnings show higher sales and EPS
Per an earnings call transcript for Q2 2026, Linde reported sales of $9.3 billion in the second quarter of 2026, representing 9 percent growth versus the same period a year earlier. The same transcript notes that adjusted earnings per share reached $4.50 in Q2 2026, an increase of 10 percent compared with the prior year quarter.
The company highlighted that these figures marked record levels of both sales and earnings per share in the quarter. In addition, management reported that the project backlog reached a new record of $8.1 billion as of Q2 2026, giving Linde a significant pipeline of future projects across industrial and medical gases.
Guidance for the full year 2026 was reaffirmed and updated in the Q2 2026 communication. According to the same Q2 2026 earnings discussion, management now expects full year 2026 adjusted earnings per share in a range of $17.70 to $17.90, which implies 8 to 9 percent growth excluding a 1 percent foreign exchange tailwind. This range is slightly higher than earlier indications for 2026 that centered on adjusted EPS growth of 6 to 9 percent with a similar foreign exchange assumption.
When the Q2 2026 figures are compared with earlier commentary on Linde's outlook for 2026, the new guidance range of $17.70 to $17.90 suggests that the company is aiming for adjusted EPS that is at least $0.30 higher than the midpoint of the previous $17.40 to $17.90 range cited in earlier discussions of the 2026 plan. This incremental lift in the lower end of the range reflects management's confidence that the combination of project execution and pricing can support higher earnings.
Stock trades close to recent highs
A recent market-data overview of Linde's stock shows that the shares closed at $490.33 on August 26, 2026 on Nasdaq, with an intraday real-time quote around $493.58 during the regular session. Another recent report focused on the shares noted that the stock was trading at approximately $490.03 on August 24, 2026 at the New York Stock Exchange and remained only a small margin below its latest record level at that time.
This positioning means that as of late August 2026, Linde stock is effectively holding just a few dollars beneath its most recent high watermark, even after recent gains. The limited gap between the recent close near $490 and the reported record level indicates that investors have continued to support the shares in the wake of the Q2 2026 results and updated guidance.
Based on recent commentary in a dividend-focused analysis, Linde's equity value has also grown substantially. The same analysis cited a market capitalization of $226.4 billion for Linde and a dividend yield of 1.3 percent as of August 2026. At a share price close to $490, this market capitalization figure suggests that Linde has maintained a position among the largest industrial companies globally, while still providing a modest cash yield to shareholders through its dividend.
For income-oriented investors, the combination of mid-single-digit to high-single-digit earnings growth guidance for 2026 and a low but stable dividend yield can be appealing. The earnings growth targeted in the Q2 2026 guidance range, coupled with the record $8.1 billion project backlog, provides a quantitative basis for viewing Linde as a company that is balancing growth and capital returns rather than focusing exclusively on one or the other.
Backlog and guidance support medium-term outlook
The Q2 2026 earnings call transcript emphasized that Linde's project backlog had climbed to $8.1 billion by the end of the quarter. This backlog represents future contracted projects across key end markets such as petrochemicals, refining, electronics, and healthcare. In practical terms, a backlog of this size, when compared with the Q2 2026 sales of $9.3 billion, indicates that Linde has close to a full quarter's worth of additional revenue potential already secured in signed contracts.
When contrasted with prior commentary at the end of 2025 that cited a record project backlog of $10 billion, the Q2 2026 figure of $8.1 billion shows that the backlog has moderated somewhat but remains elevated by historical standards. In late 2025, Linde reported adjusted earnings per share of $4.20 in the fourth quarter of 2025, with full year 2025 revenue of $34 billion and an earlier 2026 EPS guidance range of $17.40 to $17.90 supported by that record $10 billion backlog. The Q2 2026 situation, with a backlog of $8.1 billion and an updated EPS guidance range of $17.70 to $17.90, demonstrates that even with a slightly smaller backlog than the late 2025 peak, the earnings outlook has moved higher.
This evolution highlights how the quality and timing of backlog conversion can matter as much as its sheer size. With Q2 2026 sales 9 percent higher year over year and adjusted EPS up 10 percent, Linde has shown that its execution on the project pipeline and pricing initiatives can support earnings growth even as the backlog shifts from $10 billion at the end of 2025 to $8.1 billion by mid-2026. For investors, the key quantitative takeaway is that the company's earnings guidance reflects not only the backlog volume but also margin management and operational efficiency.
The updated full year 2026 EPS guidance range of $17.70 to $17.90 also implies a notable step up from the reported adjusted EPS for 2025. Based on the earlier full year 2025 revenue of $34 billion and the Q4 2025 adjusted EPS of $4.20, the 2026 guidance range indicates that management expects to deliver earnings growth on top of what was already a record performance in 2025. The fact that the guidance calls for 8 to 9 percent EPS growth in 2026, compared with earlier references to 6 to 9 percent growth in prior communications, underscores that Linde is tracking toward the higher end of its previous ambitions.
In the context of the broader industrial-gases sector, such a combination of mid-to-high single digit EPS growth, a large but manageable backlog, and a market capitalization above $200 billion places Linde firmly in the category of mature growth companies. Quantitatively, the relationship between the $226.4 billion market cap and the expected 2026 EPS range can also inform valuation metrics such as price-to-earnings ratio, although those calculations depend on the exact share count and prevailing share price at any given time.
Industrial gases support diverse end markets
Linde's business centers on the production and distribution of industrial and medical gases, such as oxygen, nitrogen, hydrogen, and specialty gases, which are critical inputs for manufacturing, healthcare, and technology industries. The project backlog of $8.1 billion as of Q2 2026 reflects long-term contracts for on-site gas supply, pipeline networks, and plant construction, among other offerings. These projects often involve multi-year commitments from customers, providing visibility into future revenue streams.
The 9 percent year-over-year increase in sales to $9.3 billion in Q2 2026 suggests that demand remains strong across several end markets, including energy transition applications like hydrogen and carbon capture, as well as more traditional sectors such as steelmaking, glass, and food processing. In addition, the 10 percent rise in adjusted EPS to $4.50 in Q2 2026 indicates that Linde is not only growing revenue but also maintaining or expanding margins, which can be a function of mix, pricing, and cost control.
From a strategic perspective, the project backlog can be seen as a quantitative indicator of future capacity expansion and customer commitments. When Linde reported a record $10 billion backlog at the end of 2025, it signaled that the company had secured a sizable portfolio of projects that would roll out over several years. The Q2 2026 backlog of $8.1 billion, while lower than the late 2025 peak, remains robust and helps underpin the full year 2026 EPS guidance. For investors, this means that the company has a substantial set of already-won business that should translate into revenue and earnings beyond 2026 as the projects come online.
The interplay between backlog, revenue growth, and EPS guidance can also be seen in the quantitative relationship between these figures. For example, the Q2 2026 sales of $9.3 billion represent a significant portion of the full year 2025 revenue of $34 billion, indicating that Linde's quarterly run rate has risen compared with the prior year. If the company were to maintain a similar quarterly sales level through the remainder of 2026, the full year revenue would likely exceed the 2025 figure, further supporting the targeted 8 to 9 percent EPS growth range.
Dividend profile and valuation context
The dividend-oriented analysis that cited Linde's market capitalization of $226.4 billion and dividend yield of 1.3 percent as of August 2026 helps frame the stock's role in income portfolios. At a share price near $490, a 1.3 percent yield corresponds to an annual dividend per share in the range of approximately $6.37, assuming the yield is calculated on a trailing basis. This level of dividend provides a modest but tangible cash return while leaving substantial free cash flow for reinvestment in projects and share repurchases.
Given the 8 to 9 percent EPS growth guidance for 2026, a 1.3 percent dividend yield suggests that a significant portion of Linde's earnings is being reinvested to support future growth or returned to shareholders through mechanisms other than cash dividends. This balance is typical for large industrial companies that need to fund capital-intensive projects while also meeting investor expectations for capital returns.
When considering valuation, investors often compare the market capitalization of $226.4 billion with the company's earnings power as indicated by the $17.70 to $17.90 EPS guidance range. While the precise price-to-earnings multiple depends on the exact share price at any given time, the combination of a high market value and robust EPS growth guidance implies that the market is willing to assign a premium multiple to Linde relative to some slower-growing industrial peers. The quantitative relationship between these figures provides a framework for assessing whether the stock is priced in line with its growth prospects.
Another way to contextualize Linde's valuation is to compare the growth in EPS with the historical performance. In Q4 2025, Linde reported adjusted EPS of $4.20, and full year 2025 revenue of $34 billion. By Q2 2026, adjusted EPS had risen to $4.50 on a quarterly basis, and the full year 2026 EPS guidance range suggests continued progression. The step from $4.20 in Q4 2025 to $4.50 in Q2 2026 represents an increase of $0.30 per share, or roughly 7.1 percent, over two quarters, highlighting the trajectory that management is targeting.
Representative application: oxygen supply solutions
One representative example of Linde's product and service portfolio is its oxygen supply solutions for healthcare and industrial clients. These offerings include on-site oxygen generation plants for hospitals, bulk delivery of liquid oxygen, and pipeline networks that supply oxygen directly to manufacturing facilities. Projects in this area often form part of the broader project backlog, contributing to the $8.1 billion backlog figure reported for Q2 2026.
In practice, oxygen supply contracts can span many years and involve custom-engineered solutions tailored to the needs of each customer. For instance, a large hospital network might contract Linde to install and operate an on-site oxygen plant that can deliver a specified volume of medical-grade oxygen per day, with Linde investing in the plant and recovering its investment through long-term supply agreements. The revenue from such projects contributes to the 9 percent year-over-year increase in sales to $9.3 billion in Q2 2026, while the associated returns support the 10 percent rise in adjusted EPS to $4.50 in the same period.
Linde stock remains supported by earnings and backlog
As of the close on August 26, 2026, Linde stock stood at $490.33 on Nasdaq, with intraday trading reflected in a real-time quote around $493.58 during the session, all in U.S. dollars. This price level, combined with a market capitalization of $226.4 billion reported in recent analysis, underscores the scale of the company and the market's confidence in its ability to deliver on the full year 2026 EPS guidance range of $17.70 to $17.90.
The combination of Q2 2026 sales of $9.3 billion, up 9 percent year over year, adjusted EPS of $4.50, up 10 percent, and a project backlog of $8.1 billion provides a quantitative foundation for that confidence. Even though the backlog has eased from a record $10 billion reported at the end of 2025, the updated guidance range suggests that Linde expects to convert its pipeline and ongoing operations into higher earnings in 2026, reinforcing the stock's position close to its recent record high.
Read more
Q2 2026 earnings call transcript for Linde
Industrial gas projects underpin growth
Linde's large-scale industrial gas projects, such as hydrogen plants, air separation units, and carbon capture installations, are a key driver of its $8.1 billion project backlog as of Q2 2026. These projects typically require substantial capital investment and long-term contracts, which in turn support revenue visibility and earnings stability. The 9 percent increase in Q2 2026 sales to $9.3 billion shows that these projects are progressing and contributing to top-line growth.
By aligning its project portfolio with global trends such as decarbonization, energy transition, and digitalization, Linde positions itself to capture demand from customers seeking to reduce emissions and improve efficiency. Quantitatively, the project backlog and guidance figures demonstrate how this strategy is translating into financial performance. The updated 2026 EPS guidance range of $17.70 to $17.90, which implies 8 to 9 percent growth excluding a 1 percent foreign exchange tailwind, suggests that Linde expects continued momentum in its core markets.
Share price context and investor takeaway
With Linde stock trading around $490 on August 26, 2026, investors can see the share price as a reflection of the company's current earnings power and growth prospects. The proximity of this price to the reported recent record level signals that the market has absorbed the Q2 2026 results and updated guidance positively, maintaining the stock's valuation near its highs.
For investors evaluating Linde, the key quantitative markers include Q2 2026 sales of $9.3 billion, adjusted EPS of $4.50, a project backlog of $8.1 billion, full year 2026 EPS guidance of $17.70 to $17.90, and a market capitalization of $226.4 billion paired with a 1.3 percent dividend yield. These figures collectively outline a picture of a large industrial company delivering steady growth while returning some cash to shareholders, with its stock price reflecting that balance as of late August 2026.
Company facts
Company: Linde plc
ISIN: IE00BZ12WP82
Ticker: LIN
Exchange: Nasdaq
Price (as of August 26, 2026, 4:00 p.m. ET): $490.33 USD
Market cap: $226.4 billion (as of August 2026)
Sector / Industry: Industrials / Industrial Gases
